NAAA-IN-1

• CAT Number: I043652
• CAS Number: 1439366-66-1
• Molecular Formula: C18H17NO4
• Molecular Weight: 311.33
• Purity: ≥95%
• Synonyms: (4-phenylphenyl)methyl N-[(2S,3R)-2-methyl-4-oxooxetan-3-yl]carbamate
• InChI: InChI=1S/C18H17NO4/c1-12-16(17(20)23-12)19-18(21)22-11-13-7-9-15(10-8-13)14-5-3-2-4-6-14/h2-10,12,16H,11H2,1H3,(H,19,21)/t12-,16+/m0/s1
• InChIKey: MFQATLPMLVIJGV-BLLLJJGKSA-N
• SMILES: C[C@H]1[C@H](C(=O)O1)NC(=O)OCC2=CC=C(C=C2)C3=CC=CC=C3

NAAA-IN-1（Cat No.:I043652）is a small molecule inhibitor designed to target N-acylethanolamine acid amide hydrolase (NAAA), an enzyme involved in the breakdown of lipid signaling molecules. NAAA plays a role in regulating inflammatory responses and pain, making it a potential target for treating conditions such as chronic pain, neuroinflammation, and other disorders related to the endocannabinoid system. By inhibiting NAAA, NAAA-IN-1 may reduce the levels of pro-inflammatory lipids, providing a novel therapeutic strategy for managing pain and inflammation. Preclinical studies are underway to assess its effectiveness and safety for clinical use.